Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

被引：6
|
作者：
VanderLaan, Paul A. [1 ,2 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
CANCER CYTOPATHOLOGY | 2019年 / 127卷 / 05期
关键词：
ALK; biomarker testing; EGFR; guideline; immunocytochemistry; immunohistochemistry; non-small cell lung cancer; NTRK; PD-L1; ROS1; IMMUNOHISTOCHEMISTRY;
D O I：
10.1002/cncy.22138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：278 / 280
页数：3
相关论文
共 50 条
  • [11] PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
    Kim, Hyojin
    Chung, Jin-Haeng
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2019, 53 (04) : 199 - 206
  • [12] Advancements in Non-Small Cell Lung Cancer Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
    Jager, Vincent D. de
    Timens, Wim
    Bayle, Arnaud
    Botling, Johan
    Brcic, Luka
    Buettner, Reinhard
    Fernandes, Maria Gabriela O.
    Havel, Libor
    Hochmair, Maximilian J.
    Hofman, Paul
    Janssens, Annelies
    Johansson, Mikael
    van Kempen, Leon
    Kern, Izidor
    Lopez-Rios, Fernando
    Luchtenborg, Margreet
    Machado, Jose Carlos
    Mohorcic, Katja
    Paz-Ares, Luis
    Popat, Sanjay
    Ryska, Ales
    Taniere, Phillipe
    Wolf, Juergen
    Schuuring, Ed
    van der Wekkenz, Anthonie J.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 38
  • [13] Biomarker testing in non-small cell lung cancer: to move forward with quality
    Rolf Stahel
    Clinical and Translational Oncology, 2012, 14 : 321 - 322
  • [14] Biomarker Testing in Non-Small Cell Lung Cancer A Clinician's Perspective
    Bernicker, Eric
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (04) : 448 - 450
  • [15] The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
    Kerr, Keith M.
    Bibeau, Frederic
    Thunnissen, Erik
    Botling, Johan
    Ryska, Ales
    Wolf, Jurgen
    Ohrling, Katarina
    Burdon, Peter
    Malapelle, Umberto
    Buttner, Reinhard
    LUNG CANCER, 2021, 154 : 161 - 175
  • [16] Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
    Ganti, Apar
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ramalingam, Suresh
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Borghaei, Hossein
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S964 - S965
  • [17] Biomarker testing in non-small cell lung cancer: to move forward with quality
    Stahel, Rolf
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (05): : 321 - 322
  • [18] What, When, and How of Biomarker Testing in Non-Small Cell Lung Cancer
    Riely, Gregory L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 686 - 688
  • [19] The rapidly evolving landscape of biomarker testing in non-small cell lung cancer
    VanderLaan, Paul A.
    Rangachari, Deepa
    Costa, Daniel B.
    CANCER CYTOPATHOLOGY, 2021, 129 (03) : 179 - 181
  • [20] Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer
    Ilie, Marius
    Beaulande, Melanie
    Hamila, Marame
    Erb, Gilles
    Hofman, Veronique
    Hofman, Paul
    LUNG CANCER, 2018, 124 : 90 - 94
12345